v3.25.1
Convertible Preferred Stock and Stockholders’ Equity - Part 3 (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 24, 2025
Sep. 26, 2024
Apr. 16, 2024
Feb. 14, 2024
May 31, 2023
May 09, 2023
Nov. 18, 2022
Nov. 10, 2022
Aug. 31, 2025
Aug. 31, 2024
Jan. 31, 2024
Mar. 31, 2025
Dec. 31, 2024
Oct. 31, 2024
Sep. 30, 2024
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Common stock issued                       36,774,006 11,767,443    
Common stock shares outstanding                       36,761,072 11,754,509    
Repurchase shares of common stock               125,000              
Price per share (in Dollars per share)             $ 2 $ 1              
Warrants outstanding fair value (in Dollars per share)                       $ 6.72      
Warrant liability (in Dollars)                       $ 52,884 $ 43,089    
Settlement share                       39,158 39,158    
Restricted shares granted         636 3,750                  
Restricted shares granted vest                   25.00% 50.00%        
Stock options outstanding     12,257                        
Expense (in Dollars)                         $ 18,000    
Weighted average exercise price (in Dollars per share)                           $ 3.46  
Forecast [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Restricted shares granted vest                 25.00%            
Warrant [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Warrants exercisable                       583,475      
Series C PIPE Warrants [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Warrant liability (in Dollars)                       $ 32,982 32,982    
Proceeds from exercise of warrants (in Dollars)                       19,902 10,200    
Equity Option [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Fair value of stock options (in Dollars)                       $ 46,000 $ 83,000    
Stock option outstanding shares                       13,674 13,674    
Weighted average exercise price (in Dollars per share)                       $ 156.96 $ 156.96    
Chief Executive Officer [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Restricted shares granted           12,188                  
Chief Financial Officer [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Restricted shares granted           3,750                  
CBO’s [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Restricted shares granted           1,875                  
Board of Directors [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Aggregate of stock options       78                      
Board of Directtors [Member[                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Restricted stock (in Dollars) $ 1,709 $ 16,590                          
Expense (in Dollars)                         $ 18,000    
Other Current Liabilities [Member] | Series C PIPE Warrants [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Contingent warrant liabilities (in Dollars)                       $ 52,884 43,089    
2022 Plan [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Reserved for issuance shares                             1,450,000
Available shares                       717,951      
PMX Option Plan [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Stock option outstanding shares                           58,172  
PMX Option Plan [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Expected term                       11 years      
Common Stock [Member] | Onconetix Equity Incentive Plans [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Reserved for issuance shares                             78,750
At the Market Offering Agreement [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Deferred offering costs (in Dollars)                         $ 300,000    
IPO [Member]                              
Convertible Preferred Stock and Stockholders Equity [Line Items]                              
Settlement share                       591,856 591,856